Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C16H18N2O4S.C15H17N |
| Molecular Weight | 545.692 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C(CC1=CC=CC=C1)NCC2=CC=CC=C2.CC3(C)S[C@@H]4[C@H](NC(=O)CC5=CC=CC=C5)C(=O)N4[C@H]3C(O)=O
InChI
InChIKey=JAQPGQYDZJZOIN-LQDWTQKMSA-N
InChI=1S/C16H18N2O4S.C15H17N/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9;1-3-7-14(8-4-1)11-12-16-13-15-9-5-2-6-10-15/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22);1-10,16H,11-13H2/t11-,12+,14-;/m1./s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [THERAPEUTIC AND METABOLIC STUDY OF BENETHAMINE-PENICILLIN]. | 1964-09-01 |
|
| [Benethamine-penicillin in the treatment of recent syphilis]. | 1963-01-01 |
|
| Some experiences with benethamine penicillin in general practice. | 1956-04 |
|
| The pharmacological properties of benethamine penicillin. | 1955-03 |
|
| Benethamine penicillin: a new salt with a prolonged action. | 1954-08-07 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13182212
Thirty-three bed patients were given a single intramuscular injection of 300,000 units
Route of Administration:
Intramuscular
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1500
Created by
admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
|
||
|
WHO-VATC |
QJ01CE91
Created by
admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
221
Created by
admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
|
PRIMARY | |||
|
65054
Created by
admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
|
PRIMARY | |||
|
DTXSID10226072
Created by
admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
|
PRIMARY | |||
|
CHEMBL29
Created by
admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
|
PRIMARY | |||
|
751-84-8
Created by
admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
|
PRIMARY | |||
|
100000086616
Created by
admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
|
PRIMARY | |||
|
DBSALT002391
Created by
admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
|
PRIMARY | |||
|
C78799
Created by
admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
|
PRIMARY | |||
|
52151
Created by
admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
|
PRIMARY | |||
|
SUB05712MIG
Created by
admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
|
PRIMARY | |||
|
212-029-8
Created by
admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
|
PRIMARY | |||
|
m8474
Created by
admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
|
PRIMARY | Merck Index | ||
|
C038323
Created by
admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
|
PRIMARY | |||
|
O3S7RWT8R5
Created by
admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD